Accessibility settings

This paper is in the following e-collection/theme issue:

Systematic Review Protocols (744) Public (e)Health, Digital Epidemiology and Public Health Informatics (2286) Obstetrics, Gynecology, and Reproductive Medicine (413) Perinatal Education for Parents (331) Opioid and Related Substance Misuse (239)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/42417, first published .
Pregnant woman holding prenatal vitamins and a glass of water

Opioid Agonist Therapies and Pregnancy Outcomes for Pregnant People With Opioid Use Disorder: Protocol for a Systematic Review

Opioid Agonist Therapies and Pregnancy Outcomes for Pregnant People With Opioid Use Disorder: Protocol for a Systematic Review

Authors of this article:

Lindsay A Wilson1 Author Orcid Image ;   Preet Gandhi1 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. Admass B, Admassie B, Chekol W, Alemu E, Melesse D, Ferede Y, Anteneh D, Zeleke M, Kassa S, Wagaw A, Nigatu S, Gebeyehu N. Barriers to opioid replacement therapy in pregnant women with opioid use disorder: a systematic review. Substance Abuse Treatment, Prevention, and Policy 2025;20(1) View
  2. Wilson L, Tobias S, Gandhi P, Nosyk B, Buxton J, Ti L. The comparative effects of prenatal exposure to methadone versus buprenorphine for opioid use disorder on neonatal outcomes: a systematic review and meta-analysis. BMC Pregnancy and Childbirth 2026;26(1) View